Annual Operating Expenses
$606.30 M
+$63.65 M+11.73%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual total operating expenses is $606.30 million, with the most recent change of +$63.65 million (+11.73%) on December 31, 2023.
- During the last 3 years, BBIO annual operating expenses has risen by +$123.57 million (+25.60%).
- BBIO annual operating expenses is now -5.74% below its all-time high of $643.23 million, reached on December 31, 2021.
Performance
BBIO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$189.26 M
+$15.04 M+8.64%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly total operating expenses is $189.26 million, with the most recent change of +$15.04 million (+8.64%) on September 30, 2024.
- Over the past year, BBIO quarterly operating expenses has increased by +$11.45 million (+6.44%).
- BBIO quarterly operating expenses is now -8.47% below its all-time high of $206.78 million, reached on March 31, 2024.
Performance
BBIO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BBIO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.7% | +6.4% |
| 3 y3 years | +25.6% | +6.4% |
| 5 y5 years | +230.1% | +6.4% |
BBIO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.7% | +11.7% | -8.5% | +54.2% |
| 5 y | 5-year | -5.7% | +99.2% | -8.5% | +104.7% |
| alltime | all time | -5.7% | +1282.4% | -8.5% | +444.1% |
BridgeBio Pharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $189.26 M(+8.6%) |
| Jun 2024 | - | $174.22 M(-15.7%) |
| Mar 2024 | - | $206.78 M(+16.3%) |
| Dec 2023 | $606.30 M(+11.7%) | $177.81 M(+10.5%) |
| Sep 2023 | - | $160.91 M(+12.0%) |
| Jun 2023 | - | $143.61 M(+15.8%) |
| Mar 2023 | - | $123.97 M(+1.0%) |
| Dec 2022 | $542.65 M(-15.6%) | $122.76 M(-0.8%) |
| Sep 2022 | - | $123.70 M(-14.6%) |
| Jun 2022 | - | $144.83 M(-4.3%) |
| Mar 2022 | - | $151.36 M(-14.5%) |
| Dec 2021 | $643.23 M | $176.95 M(+17.7%) |
| Sep 2021 | - | $150.39 M(+1.7%) |
| Jun 2021 | - | $147.93 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $167.97 M(+31.6%) |
| Dec 2020 | $482.73 M(+58.6%) | $127.61 M(-0.4%) |
| Sep 2020 | - | $128.07 M(+2.8%) |
| Jun 2020 | - | $124.57 M(+21.5%) |
| Mar 2020 | - | $102.49 M(+10.8%) |
| Dec 2019 | $304.30 M(+65.7%) | $92.46 M(+17.4%) |
| Sep 2019 | - | $78.77 M(+13.6%) |
| Jun 2019 | - | $69.32 M(+8.7%) |
| Mar 2019 | - | $63.75 M(-2.8%) |
| Dec 2018 | $183.66 M(+318.8%) | $65.58 M(+58.2%) |
| Sep 2018 | - | $41.46 M(+19.2%) |
| Jun 2018 | - | $34.78 M(-16.9%) |
| Mar 2018 | - | $41.84 M |
| Dec 2017 | $43.86 M | - |
FAQ
- What is BridgeBio Pharma annual total operating expenses?
- What is the all time high annual operating expenses for BridgeBio Pharma?
- What is BridgeBio Pharma annual operating expenses year-on-year change?
- What is BridgeBio Pharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly operating expenses year-on-year change?
What is BridgeBio Pharma annual total operating expenses?
The current annual operating expenses of BBIO is $606.30 M
What is the all time high annual operating expenses for BridgeBio Pharma?
BridgeBio Pharma all-time high annual total operating expenses is $643.23 M
What is BridgeBio Pharma annual operating expenses year-on-year change?
Over the past year, BBIO annual total operating expenses has changed by +$63.65 M (+11.73%)
What is BridgeBio Pharma quarterly total operating expenses?
The current quarterly operating expenses of BBIO is $189.26 M
What is the all time high quarterly operating expenses for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly total operating expenses is $206.78 M
What is BridgeBio Pharma quarterly operating expenses year-on-year change?
Over the past year, BBIO quarterly total operating expenses has changed by +$11.45 M (+6.44%)